Ciloa’s team will  be pleased to present its last progress on extracellular vesicle (EV) editing and production. Come visit us…

Ciloa secures €5 million for the development of its new generation of biomedicines and vaccines using exosomes The company finalized…

Ciloa is pleased to be a partner of the 5th edition of the France Bioproduction congress. Meet Robert Mamoun, Philippe…

Ciloa is pleased to join its partner Sanofi at the Viva Technology Conference 2021, the world’s rendezvous for startups and leaders…

Ciloa’s project among the 11 winners of the “Sanofi iTech Awards”  French biotech company Ciloa wins the 2020 “Sanofi iTech…

The French biotech company CILOA creates its new GMP-compliant production unit as part of the development of a new generation…